Fang, Boyan

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

Jia, L., Du, Y., Chu, L., Zhang, Z., Li, F., Lyu, D., Li, Y., Li, Y., Zhu, M., Jiao, H., et al. (2020) · The Lancet Public Health

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 1,829

The cost of Alzheimer's disease in China and re‐estimation of costs worldwide

Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., Zhao, L., Jin, H., Xu, H., Wang, F., et al. (2018) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 752

Circular RNAs in Parkinson’s Disease: Reliable Biological markers and targets for Rehabilitation

Duan, Y., Wang, Y., Liu, Y., Jin, Z., Liu, C., Yu, X., Chen, K., Meng, D., Xi, J., & Fang, B. (2022) · Molecular Neurobiology

Circular RNAs in diseasesParkinson's Disease Mechanisms and Treatments

Cited by 17

Circular RNAs in Parkinson’s Disease: Reliable Biological Markers and Targets for Rehabilitation

Duan, Y., Wang, Y., Liu, Y., Jin, Z., Liu, C., Yu, X., Chen, K., Meng, D., Xi, J., & Fang, B. (2023) · Molecular Neurobiology

Circular RNAs in diseasesParkinson's Disease Mechanisms and Treatments

Cited by 17